(Q39583380)

13 September 2017

Initiatives to improve prescribing efficiency for drugs to treat Parkinson's disease in Croatia: influence and future directions (English)

1 reference

13 September 2017

0 references

1 reference

Ljiljana Sovic Brkicic

1

1 reference

13 September 2017

Brian Godman

2

1 reference

13 September 2017

Luka Voncina

3

1 reference

13 September 2017

Slavica Sovic

4

1 reference

13 September 2017

Maja Relja

5

1 reference

13 September 2017

1 June 2012

1 reference

Expert Review of Pharmacoeconomics & Outcomes Research

13 September 2017

1 reference

13 September 2017

12

1 reference

13 September 2017

3

1 reference

13 September 2017

373-384

1 reference

Ongoing pharmaceutical reforms in France: implications for key stakeholder groups

13 September 2017

1 reference

Recent national and regional drug reforms in Sweden: implications for pharmaceutical companies in Europe.

21 January 2018

1 reference

Use of Generics-A Critical Cost Containment Measure for All Healthcare Professionals in Europe?

21 January 2018

1 reference

Policies to enhance the efficiency of prescribing in the Spanish Catalan region: impact and future direction

21 January 2018

1 reference

Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications

21 January 2018

1 reference

Insight into recent reforms and initiatives in Austria: implications for key stakeholders

21 January 2018

1 reference

Policies to enhance prescribing efficiency in europe: findings and future implications

21 January 2018

1 reference

Influence of demand-side measures to enhance renin-angiotensin prescribing efficiency in Europe: implications for the future

21 January 2018

1 reference

Impact of recent reforms in Austria on utilization and expenditure of PPIs and lipid-lowering drugs: implications for the future

21 January 2018

1 reference

Stratum-specific positive predictive values of claims for acute pancreatitis among commercial health insurance plan enrollees with diabetes mellitus.

21 January 2018

1 reference

Croatian 2008-2010 health insurance reform: hard choices toward financial sustainability and efficiency

21 January 2018

1 reference

Having your cake and eating it: office of fair trading proposal for funding new drugs to benefit patients and innovative companies

21 January 2018

1 reference

Success and problems of long-term levodopa therapy in Parkinson's disease

21 January 2018

1 reference

Economic evidence in Parkinson's disease: a review

21 January 2018

1 reference

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa

21 January 2018

1 reference

The increased utilisation of dopamine agonists and the introduction of COMT inhibitors have not reduced levodopa consumption--a nation-wide perspective in Sweden

21 January 2018

1 reference

Pharmacological treatment of Parkinson's disease

21 January 2018

1 reference

Dopamine agonists: their role in the treatment of Parkinson's disease

21 January 2018

1 reference

Alternatives to levodopa in the initial treatment of early Parkinson's disease

21 January 2018

1 reference

Determinants of the timing of symptomatic treatment in early Parkinson disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience

21 January 2018

1 reference

Drug prescribing patterns in Parkinson's disease: a pharmacoepidemiological survey in a cohort of ambulatory patients

21 January 2018

1 reference

The prevalence of Parkinson's disease in British Columbia, Canada, estimated by using drug tracer methodology

21 January 2018

1 reference

Potential savings without compromising the quality of care

21 January 2018

1 reference

Different versions of the anatomical therapeutic chemical classification system and the defined daily dose--are drug utilisation data comparable?

21 January 2018

1 reference

Coping with changes in the Defined Daily Dose in a longitudinal drug consumption database

21 January 2018

1 reference

The treatment of early Parkinson's disease: levodopa rehabilitated

21 January 2018

1 reference

Levodopa: back to the future.

21 January 2018

1 reference

A brief history of levodopa

21 January 2018

1 reference

Medical management of levodopa-associated motor complications in patients with Parkinson's disease

21 January 2018

1 reference

Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis

21 January 2018

1 reference

Initial therapy for Parkinson's disease: levodopa vs. dopamine receptor agonists

21 January 2018

1 reference

Clinical practice. Restless legs syndrome

21 January 2018

1 reference

Enhancing the rational use of new medicines across European health care systems

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERP.12.24

1 reference

13 September 2017

1 reference